Lodo Therapeutics Corporation

📍 New York, United States🗓 Founded 2015👥 6 employees💰 Last funded Aug 2019
Biotechnology🌐 lodotherapeutics.com
Website LinkedIn
Lodo Therapeutics discovers and develops novel therapeutics addressing "undruggable" targets with high unmet need by applying its proprietary platform to tap the vast collections of undiscovered molecules encoded in environmental microbial DNA. These drug-like molecules span an enormous range of structural diversity and their biological relevance has been optimized by a billion years of evolution. Lodos proprietary platform leverages breakthroughs in next-generation sequencing, artificial intelligence/machine learning and synthetic biology to increase the speed and efficiency of natural products drug discovery by orders of magnitude. Following successful initial collaborations with two global partners, Lodo is developing an internal pipeline initially focusing on oncology drugs and is expanding its partnering activities in a range of indications
3
Total investors
2
Early stage
1
Mid stage
0
Late stage
2015
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2016–2019 · investors recorded per year
201612017120191
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Lodo Therapeutics Corporation?
Lodo Therapeutics Corporation has 3 investors on record on gritt.io, including 2 early-stage backers, 1 mid-stage.
When did Lodo Therapeutics Corporation last raise funding?
The most recent investment in Lodo Therapeutics Corporation recorded on gritt.io was in August 2019.
When was Lodo Therapeutics Corporation founded?
Lodo Therapeutics Corporation was founded in 2015.
What industry is Lodo Therapeutics Corporation in?
Lodo Therapeutics Corporation operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Lodo Therapeutics Corporation based?
Lodo Therapeutics Corporation is headquartered in New York, United States.